Skip to main content
ZBIO logo
ZBIO
(NASDAQ)
Zenas BioPharma, Inc.
$21.46-- (--)
Loading... - Market loading

Zenas BioPharma (ZBIO) Stock Price & Financial Analysis

Zenas BioPharma Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$19.81 - $22.15
52-Week High$44.60
52-Week Low$6.11
Open$20.12
Volume1.72M
Average Volume (3M)1.72M
Market Cap904.74M
Shares Outstanding42.16M
Price to Sales (P/S)57.22
Price to Book (P/B)4.37
EV/EBITDA-3.80
Revenue (TTM)15.00M
Net Income (TTM)-189.90M
Free Cash Flow (TTM)-163.56M
EPS (TTM)$-4.50
Profit Margin-1265.99%
Operating Margin-1304.64%
Return on Equity (ROE)-96.68%
Debt to Equity0.00
50-Day MA$22.99
200-Day MA$23.17
52-Week Change167.89%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Zenas BioPharma

What is the current stock price for ZBIO?

As of the latest trading session, ZBIO stock trades at $21.46. The 52-week range is $6.11–$44.60, with a day range of $19.81–$22.15.

What is the P/E ratio for ZBIO?

The P/E ratio (Price-to-Earnings) for ZBIO is shown in the Key Statistics section. This valuation metric helps compare Zenas BioPharma, Inc. to industry peers.

Does ZBIO pay dividends?

Zenas BioPharma does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ZBIO?

Based on 4 analysts, the consensus for ZBIO is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ZBIO?

Zenas BioPharma's market capitalization is $904.7M, classifying it as a small-cap company. Zenas BioPharma operates in the Healthcare sector within the Biotechnology industry.